Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

16 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Expression of retinoblastoma gene (Rb) protein in T12M0 prostatic adenocarcinoma.
Vesalainen S, Lipponen P. Vesalainen S, et al. J Cancer Res Clin Oncol. 1995;121(7):429-33. doi: 10.1007/BF01212951. J Cancer Res Clin Oncol. 1995. PMID: 7635874
Value of Ki-67 immunolabelling as a prognostic factor in prostate cancer.
Aaltomaa S, Lipponen P, Vesalainen S, Ala-Opas M, Eskelinen M, Syrjänen K. Aaltomaa S, et al. Among authors: vesalainen s. Eur Urol. 1997;32(4):410-5. Eur Urol. 1997. PMID: 9412797
Expression of the apoptosis suppressing protein bcl-2 in prostatic adenocarcinoma is related to tumor malignancy.
Lipponen P, Vesalainen S. Lipponen P, et al. Among authors: vesalainen s. Prostate. 1997 Jun 15;32(1):9-15. doi: 10.1002/(sici)1097-0045(19970615)32:1<9::aid-pros2>3.0.co;2-i. Prostate. 1997. PMID: 9207952
A prognostic score for prostatic adenocarcinoma based on clinical, histological, biochemical and cytometric data from the primary tumour.
Lipponen P, Vesalainen S, Kasurinen J, Ala-Opas M, Syrjänen K. Lipponen P, et al. Among authors: vesalainen s. Anticancer Res. 1996 Jul-Aug;16(4A):2095-100. Anticancer Res. 1996. PMID: 8712749
Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
Vesalainen S, Nordling S, Lipponen P, Talja M, Syrjänen K. Vesalainen S, et al. Br J Cancer. 1994 Aug;70(2):309-14. doi: 10.1038/bjc.1994.298. Br J Cancer. 1994. PMID: 8054280 Free PMC article.
Tumor vascularity and basement membrane structure as prognostic factors in T1-2MO prostatic adenocarcinoma.
Vesalainen S, Lipponen P, Talja M, Alhava E, Syrjänen K. Vesalainen S, et al. Anticancer Res. 1994 Mar-Apr;14(2B):709-14. Anticancer Res. 1994. PMID: 8010731
Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma.
Vesalainen S, Lipponen P, Talja M, Syrjänen K. Vesalainen S, et al. Eur J Cancer. 1994;30A(12):1797-803. doi: 10.1016/0959-8049(94)e0159-2. Eur J Cancer. 1994. PMID: 7880609
Biochemical parameters as prognostic factors in prostatic adenocarcinoma.
Vesalainen S, Lipponen P, Talja M, Syrjänen K. Vesalainen S, et al. Acta Oncol. 1995;34(1):53-9. doi: 10.3109/02841869509093639. Acta Oncol. 1995. PMID: 7865237
Mitotic activity and prognosis in prostatic adenocarcinoma.
Vesalainen S, Lipponen P, Talja M, Syrjänen K. Vesalainen S, et al. Prostate. 1995 Feb;26(2):80-6. doi: 10.1002/pros.2990260204. Prostate. 1995. PMID: 7855001
Results of the primary treatment in T1-3M0 prostatic adenocarcinoma are dependent on tumour biology.
Vesalainen S, Lipponen P, Nordling S, Talja M, Syrjänen K. Vesalainen S, et al. Anticancer Res. 1995 Mar-Apr;15(2):569-73. Anticancer Res. 1995. PMID: 7763039
16 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback